Advanced Ovarian Cancer with Thermochemotherapy and Adjuvant Immune Therapy

R. Kleef S. Kekic N. Ludwig

Dr. Kleef – Hyperthermie, Stiftung Integrative Onkologie, Vienna, Austria

Abstract
We report on a 4-year progression-free survival of a 54-year-old female first diagnosed in December 2007 with advanced bilateral ovarian cancer FIGO IIIc, disseminated peritoneal carcinosis and malignant diaphragm invasion. Treatment started in January 2008 with 6 cycles of Taxol 175 mg/m2/carboplatin AUC 5 in 3-week intervals. Twenty-four hours following each chemotherapy session, fever-range long-duration whole-body hyperthermia (WBH) was performed at the temperature plateau of 40°C body core temperature for 6 h. Three months after completion of chemotherapy, 4 more long-duration WBH procedures were performed in monthly intervals. Importantly, long-duration WBH was paralleled with intradermal vaccination of autologous dendritic cells. No other treatment was given to the patient. Four years following the first diagnosis, the patient is still in complete remission with no evidence of disease.

Kleef R 2012 WBH Advanced Ovarian CA Report
Kleef R 2012 WBH Advanced Ovarian CA Report
Kleef R 2012 WBH Advanced Ovarian CA Report.pdf
592.4 KiB
944 Downloads
Details